Skip to content

ASP BELGIUM

Active
Private limited companyfounded 2018active for 8 yearsSint-Lazaruslaan 4-10, 1210 Sint-Joost-ten-Node, Belgium251 active companies are registered at this addressKBO/BCE: BE 0691.974.442
Summary

ASP BELGIUM has been active since 2018 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €2.3m and a net result of €121,694. The figures fluctuate too strongly year-on-year for a reliable trend projection. Its solvency ranks better than 82% of 9,748 sector peers (NACE 46, financial year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).

Overview

Activity
Wholesale of pharmaceutical and medical goods
NACE 46460
10th largest company by equity in Sint-Joost-ten-Node, Wholesale and retail trade sector1 site
Size
€2.9mtotal assets 2025
Staff
5 FTE
Equity
€2.3m
Profit
€121,694
Turnover not published (abbreviated format)
Financial health
95 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
0.1%
Structure
Auditor: EY Bedrijfsrevisoren BVAccounts 24 days early9 of 18 deeds read
Why 95raises risk1 change of registered office in 24 monthslowers riskLiquidity: current ratio 4.25, cash €1.6mFigures for financial year 2025 (filed 07-07-2026)Equity €2.3m (77.6% of total assets)Show the evidence

Checked score

Score 2025
95 / 100
Excellent
Probability in this band: under 0.55%
Financially better than 75% of its sector peers (NACE 46, micro)
Financial strength · tick = 2024
Strong
Solvency 100=
equity 77.6% of total assets
Liquidity 94-2
short-term debt 19.3% · cash 55.4%
Profitability 74+1
return on assets 4.2%
Bankruptcy probability, 12 months
0.1% Very low
0%0.5%1.5%4%10%≥ 25%

About 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.4% (26,871 companies, NACE 46, micro)
Last 24 months 11-2024: 1.3% 12-2024: 1.3%● unchanged vs 11-2024 01-2025: 1.3%● unchanged vs 12-2024 02-2025: 2.1%▲ +0.8 percentage points vs 01-2025 03-2025: 2.4%▲ +0.3 percentage points vs 02-2025 04-2025: 2.6%▲ +0.2 percentage points vs 03-2025 05-2025: 2.8%▲ +0.2 percentage points vs 04-2025 06-2025: 3.3%▲ +0.5 percentage points vs 05-2025highest value 07-2025: 3.3%● unchanged vs 06-2025highest value 08-2025: 0.3%▼ -3.0 percentage points vs 07-2025 09-2025: 0.3%● unchanged vs 08-2025 10-2025: 0.3%● unchanged vs 09-2025 11-2025: 0.3%● unchanged vs 10-2025 12-2025: 0.3%● unchanged vs 11-2025 01-2026: 0.3%● unchanged vs 12-2025 02-2026: 0.3%● unchanged vs 01-2026 03-2026: 0.3%● unchanged vs 02-2026 04-2026: 0.3%● unchanged vs 03-2026 05-2026: 0.3%● unchanged vs 04-2026 06-2026: 0.4%▲ +0.1 percentage points vs 05-2026 07-2026: 0.5%▲ +0.1 percentage points vs 06-2026 08-2026: 0.1%▼ -0.4 percentage points vs 07-2026lowest value 09-2026: 0.1%● unchanged vs 08-2026lowest value 10-2026: 0.1%● unchanged vs 09-2026lowest value
Credit of up to €210,000 on 30-day terms is acceptable
Liquidity ample (current ratio 4.25, compared with 4.5 in 2024, above the usual 1.5; short-term debt: 19.3% and cash: 55.4% of total assets), and 22.4% of the assets are financed with debt and provisions.
How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 46, micro): better than 90% on solvency, 92% on liquidity, 61% on profitability and 57% on growth.

The bankruptcy probability was computed on 22-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Five signals.
lowers riskraises riskneutral
lowers risk · Liquidity: current ratio 4.25, cash €1.6m
NBB · annual accounts
lowers risk · Figures for financial year 2025 (filed 07-07-2026)
NBB · annual accounts
raises risk · 1 change of registered office in 24 months
Belgian Official Gazette
lowers risk · Equity €2.3m (77.6% of total assets)
NBB · annual accounts
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 07-07-2026, 24 days ahead of the deadline.
NBB · 8 filings
Deviation from the deadline
2025
24 days early
2024
31 days early
2023
30 days early
2022
66 days late
2021
73 days late
2020
52 days late
2019
45 days late
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 22 days after the deadline; the sector median (NACE 46) for financial year 2024 is 3 days before the deadline, and 39% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 7 July (4 of the last 5 filed years within 90 days of that day).
Companies Code · seven months
Where today falls in the filing period
23-10-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
Searched since 2021.
KBO publications · our coverage
  1. Reappointment: EY BEDRIJFSREVISOREN BV (statutory auditor)Power of attorney
  2. Annual accounts filedfinancial year 2025 · abbreviated…
  3. Highest result from 2018 to 2025net €121,694 ▲33.4%

Key points

  • Positive: Among the best 10% on equitysector median €366,811 · 9,744 companies €2.3m View
  • Known shareholdersaccounts at 31-12-2025 100% View
  • Board3 directors in office 3 View

By topic

Financials

Financial year
2025
Total assets
€2.9m
Profit
€121,694
Solvency
77.6%
Total assets▲ 9.3%
Net result
20182025
Go to Financials

Board & ownership

Board
3 members
Known shareholders
100%
Auditor
EY Bedrijfsrevisoren BV
  • Christos ASIMAKOPOULOSDirector
  • Diana LOPEZ ECHEVERRIDirector
  • Michael EWALDDirector
Go to Board & ownership

Timeline

Events
23
Since
2019
Next accounts
by 31-07-2027
  1. 16-07-2025Permanent representative: Marleen DEFOER
  2. 30-06-2025Annual accounts filed
  3. 08-01-2025Registered office
Go to Timeline

Company details

Sites
1
Legal form
Private limited company
Activity
Wholesale of pharmaceutical and medical goodsNACE 46460
Founded
13-03-2018
Year ends
31-12
Peppol
Reachable for e-invoices
Go to Company details

Go further with this company

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.